.png)
Decreasing costs, improved technologies, and increased prevalence of chronic and infectious disease are driving an explosion in the use of genetic testing across research, clinical trials, and public health. Healthcare is on the cusp of an unprecedented opportunity to integrate sequencing as a core initiative which not only improves individual patient outcomes and population-scale research, but reduces burden on stressed health systems and opens the door to international collaboration on an unparalleled scale.
Our latest whitepaper, “The importance of genetic testing as a public health initiative: A strategic approach to integration and global collaboration” explores each of these aspects and covers:
- Genetic sequencing today: Growing public sector investment in genetic testing and the advent of Precision Public Health
- Why genetic testing integration matters: From risk and early disease detection to the benefits of scaling to population-level sequencing
- The current status of population-based genetic testing: Newborn screening programs from across the globe and how population-scale databases are powering research
- Building a strategic framework for implementation: Evidence, infrastructure, education and ethics
The paper highlights the evolving concept of Precision Public Health, what it means for both patients and population-scale research, and how it complements the precision medicine movement. It also dives into policy and the need to establish interdisciplinary, internationally applicable frameworks to enable successful global collaboration and ensure all ethical and safety considerations are met.
Interested in finding out more about how genomic testing and tailored patient engagement can support your latest research initiative? Download the whitepaper to explore how building greater public trust is vital to the successful integration of genetic testing initiatives in healthcare.
